Browse by year:

June - 2013 - issue > CIO Insights

New Modes of Technology play a Monumental Role in Life Sciences Organization

Srivatsan Krishnan
Head, BBRC Informatics/IT-Bristol-Myers Squibb
Thursday, May 30, 2013
Srivatsan Krishnan
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. Headquartered in New York City, the company has a market cap of $77.86 billion.>/i>

Whether it is using data to analyze the best targeted and most effective therapeutic techniques, or using social media to engage with customers, new modes of technology will continue to play a role in life sciences organization.

Current Trends in the Industry

From a technology standpoint, there is a wide array of technology trends that are relevant to the Pharmaceutical industry. Information Security, digital identity management, collaboration enablers such as video conferencing and Sharepoint, social media, cloud computing, big data and mobile computing are some of the areas that appear to be vibrant. Big data analytics is a particularly interesting one considering its potential to help address real-world issues such as cost of healthcare, with potential benefits across the healthcare value chain beginning with the patient. This is a particularly interesting area considering that it can be a confluence of patient medical records, genomic data and other data managed by other participants in this value chain. Starting with patient enrollment for clinical trials all the way through to helping patients and care providers determining course of treatment, this is one very interesting area.

Bridging Business and Service

Share on Twitter
Share on LinkedIn
Share on facebook